ProMIS Neurosciences Insider ownership
What is the Insider ownership of ProMIS Neurosciences?
The Insider ownership of ProMIS Neurosciences, Inc. is 10.14%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on TSX compared to ProMIS Neurosciences
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Companies with insider ownership similar to ProMIS Neurosciences
- Galiano Gold has Insider ownership of 10.12%
- The North American Income Trust Plc has Insider ownership of 10.12%
- Universal Insurance Inc has Insider ownership of 10.13%
- Western Alaska Minerals Corp has Insider ownership of 10.13%
- Spectrum Pharmaceuticals has Insider ownership of 10.14%
- Nearmap Ltd has Insider ownership of 10.14%
- ProMIS Neurosciences has Insider ownership of 10.14%
- Conquest Resources has Insider ownership of 10.15%
- Nephros has Insider ownership of 10.15%
- Nephros has Insider ownership of 10.15%
- Nephros has Insider ownership of 10.15%
- Nephros has Insider ownership of 10.15%
- Nephros has Insider ownership of 10.15%